AmCAD-UT

by AmCad BioMed Corporation  · Based in Taiwan → — Pioneering Ultrasound AI The Future of Ultrasound Imaging is Here
Endocrinology Otolaryngology (ENT) Radiology

Subscription-based
Regulatory Status Disclosed

Overview

AmCAD-UT is an innovative AI-powered software solution developed by AmCad BioMed Corporation, designed to revolutionize thyroid ultrasound examinations. It assists medical professionals in the detection, analysis, and characterization of thyroid nodules, aiming to enhance diagnostic accuracy and streamline clinical workflows. The system utilizes patented image analysis technology to capture and quantify clinical diagnostic features from 2D ultrasound images, providing detailed color-coded visualizations of nodule characteristics such as echogenicity, shape, margins, and calcifications.

AmCAD-UT integrates seamlessly into existing workflows by offering automatic nodule detection and contouring, instant TI-RADS analysis (supporting 8 major guidelines), and automated report generation. This reduces manual tracing and provides fast, consistent, and objective risk stratification. Studies have shown that AmCAD-UT can significantly improve diagnostic performance, with reported increases in overall AUC, specificity, and sensitivity, particularly in challenging cases. It supports both real-time AI detection with handheld ultrasound devices and DICOM analysis on PCs, offering cross-platform flexibility on Android and Windows.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered real-time guidance for identifying thyroid structure and alerting suspicious findings
  • Automatic Nodule Detection & Contouring
  • Instant TI-RADS Analysis (supports 8 major TI-RADS guidelines)
  • Automated Report Generation
  • Color-Coded Nodule Features (visualizes echogenicity, shape, margins, calcifications)
  • Quantified Nodule Sonographic Characteristics
  • Cross-platform flexibility (Android and Windows platforms)
  • DICOM analysis on PC and PACS compatible
  • Enhances diagnostic accuracy (e.g., +8.8% overall AUC, +55% specificity, +30% sensitivity)
  • Supports B-mode ultrasound image analysis

Use Cases

  • Assessing thyroid nodules with ultrasound
  • Early detection and diagnosis of thyroid cancer
  • Reducing indeterminate thyroid nodule cases
  • Streamlining thyroid ultrasound workflow
  • Assisting sonographers in diagnosing Thyroid Imaging Reporting and Data System (TI-RADS) grade 3 and 4 lesions
  • Post-acquisition analysis of thyroid ultrasound images

What Physicians Need to Know

Key Capabilities
AmCAD-UT is an AI-assisted solution for thyroid nodule assessment. It offers automated nodule detection and contouring, instant TI-RADS analysis, and automated report generation. The system visualizes key characteristics such as echogenicity, shape, margins, and calcifications using patented visualization technology. It supports 8 major TI-RADS guidelines and quantifies the malignancy level of key sonographic features using patented algorithms. AmCAD-UT can analyze static images of thyroid nodules after image acquisition and can also provide real-time AI detection with handheld ultrasound devices. It evaluates nodule shape, margins, and anechoic and hyperechoic areas, applying seven scoring systems to analyze the risk of malignancy. The software provides quantification and visualization of sonographic characteristics to aid in diagnostic decisions. It can also segment and analyze thyroid ultrasound images, send DICOM images to PACS, and recommend follow-up or fine needle aspiration (FNA) based on the analysis.
Clinical Utility
AmCAD-UT assists physicians in thyroid nodule assessment with high accuracy and efficiency, aiming to streamline workflows, enhance diagnostic accuracy, and elevate patient care. It helps in the detection and diagnosis of thyroid cancer, providing a non-invasive assessment tool. The system has been shown to improve the benign tumor detection rate by 47% compared to traditional tests and achieve a 100% malignant tumor detection rate in some studies. It reduces reader subjectivity and has demonstrated more reliability in analyzing unclear or misleading images compared to clinical observers. The tool can standardize longitudinal active surveillance measurements, which is crucial for managing small changes that might trigger management escalation. It can also help reduce unnecessary biopsies and surgeries by providing more accurate diagnostic information.
Integration Options
AmCAD-UT supports B-mode ultrasound image analysis on Android and Windows platforms. It can analyze DICOM files from any ultrasound machine and is PACS compatible. The system can be integrated into a standard reading environment (PACS), via an AI marketplace or distribution platform, or used as a standalone web-based solution. It can be deployed either cloud-based or locally on dedicated hardware. AmCad BioMed has integrated its AI ultrasound technology with major international POCUS (Point-of-Care Ultrasound) manufacturers to develop handheld devices with real-time AI diagnostic and analysis capabilities.
Compliance Status
AmCAD-UT is the first thyroid cancer ultrasound CAD system with FDA 510(k) Clearance, CE Mark Certificate, and Taiwan Medical Device Marketing Approval. It is a Class IIa medical device under CE Certification (MDD pathway) and Class II under FDA Certification (510(k) cleared).
Pricing Model
The pricing model for AmCAD-UT is subscription-based, determined by the number of analyses or installations. The company is also testing features to run AmCAD-UT through web browsers, which would enable cloud analysis and online payment services.
User Experience
The program is easy to operate through a user-friendly interface. It automatically identifies and outlines nodules as soon as an image is loaded, eliminating the need for manual tracing. It provides instant TI-RADS analysis, extracting key sonographic features and delivering a TI-RADS score within seconds, ensuring fast, consistent, and objective results. An automated diagnostic report is generated, ready for review and export.
Support Quality
AmCad BioMed aims to provide real-time technical support to satisfy all AmCAD-UT users, especially with the development of web-based cloud analysis and online payment services.
Implementation Complexity
AmCAD-UT can work with either JPEG or DICOM images. The program performs analyses from an external USB drive device. Key issues in implementation include integration with radiologist interpretation, impact on workflow and efficiency, and performance monitoring. The system can be deployed either cloud-based or locally on dedicated hardware.
Evidence Base
AmCAD-UT's accuracy has been reported to reach 90%. Research indicates that it improves the benign tumor detection rate by 47% and achieves a 100% malignant tumor detection rate compared to traditional tests. Studies have shown that the AI system for thyroid nodules demonstrated more reliability in the analysis of unclear or misleading images compared to clinical observers. The system has been validated in studies for its detection and quantification of sonographic features against ground truth established by thyroid specialists. It has also been shown to produce reproducible size measurements comparable with expert radiologist assessment. The system's performance for prediction of malignancy differs between tools, and its AI-derived TIRADS classifications based on static images showed only fair agreement with systematic downgrading, suggesting its primary role for consistent longitudinal measurement tracking rather than independent TI-RADS risk categorization. The company has published research in leading otolaryngology and sleep journals.
Physician Tip

AmCAD-UT can significantly enhance diagnostic accuracy and streamline workflows for thyroid nodule assessment. While the AI provides objective quantification and risk stratification, it's important to integrate its findings with real-time sonographic context and clinical judgment, especially for TI-RADS classifications. The tool is particularly valuable for standardizing longitudinal measurements in active surveillance. Ensure high-quality ultrasound images for optimal performance of the CAD system. The system's ability to support multiple TI-RADS guidelines allows for flexibility in clinical practice. Consider using it as a reliable adjunct to reduce inter-observer variability and improve diagnostic confidence, particularly in challenging cases.

AmCAD-UT offers broad integration capabilities, supporting DICOM files from various ultrasound machines and being PACS compatible. Its cross-platform flexibility (Android and Windows) and potential for cloud-based or local deployment provide diverse integration options. The ongoing development for web browser access and real-time AI detection with handheld ultrasound devices further expands its integration potential into existing clinical workflows and emerging point-of-care ultrasound solutions.

Details

Category Endocrinology & Metabolic AI, Radiology & Imaging AI
Pricing Subscription-based
DeploymentCloud-based, Locally on dedicated hardware, or Stand-alone web-based.
Mobile AppAmCAD-UT supports B-mode ultrasound image analysis on Android and Windows platforms.
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Endocrinology, Otolaryngology (ENT), Radiology

Support & Reliability

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2021-09-08K203555 510(k)AmCAD-UT

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate AmCAD-UT

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for AmCAD-UT.

View all on YouTube

Frequently Asked Questions

AmCAD-UT is an AI-assisted solution that helps endocrinologists assess thyroid nodules by automatically detecting and contouring nodules on ultrasound images. It provides instant TI-RADS scoring and generates diagnostic reports, aiming to enhance diagnostic accuracy and streamline workflows. The system visualizes key characteristics like echogenicity, shape, margins, and calcifications using patented technology and supports eight major TI-RADS guidelines.
AmCAD-UT has received FDA 510(k) Clearance, CE Mark Certificate, and Taiwan Medical Device Marketing Approval. It is a Windows-based computer-aided detection (CADe) device intended to assist medical professionals in analyzing thyroid ultrasound images acquired from FDA-cleared ultrasound systems.
While AmCAD-UT provides reproducible size measurements, its AI-derived TI-RADS classifications based on static images have shown only fair agreement with systematic downgrading, which may be due to the loss of real-time sonographic context. The device is intended for use on ultrasound images of discrete thyroid nodules larger than 1cm. Additionally, some studies have noted that the detection accuracies for heterogeneous texture and indistinct margins appeared lower compared to anechoic areas, hyperechoic foci, and hypoechoic patterns.
Several other AI methods based on ultrasound radiomic features have been approved, including S-Detect 2, Koios DS, and Medo Thyroid. S-Detect 2, for example, is integrated into vendor-specific ultrasound machines for real-time analysis, while AmCAD-UT is a standalone software that analyzes static images.
AmCAD-UT is offered under a subscription pricing model. The cost is based on factors such as the number of analyses performed or the number of installations. Specific pricing details are not publicly available and would likely require direct inquiry with the vendor.

Related Tools

EatLove
EatLove
Endocrinology & Metabolic AI
EatLove is an AI-powered digital health platform that provides personalized nutrition plans and meal recommendations for patients, designed to be used by healthcare professionals.
CGM Analytics (CompuGroup Medical)
CompuGroup Medical
Endocrinology & Metabolic AI
CGM Analytics is a healthcare data aggregation and analytics software solution for physician practices to analyze patient data and manage populations.
AI Health Clinic
AI Health Clinic
Clinical Decision Support & Reference
AI Health Clinic provides AI that amplifies clinicians by analyzing CGM, body composition, labs, and wearables to create a metabolic index, triage patients, and draft care plans for physician approval.
90Health
90Health
Endocrinology & Metabolic AI
90Health offers a complete digital solution for managing chronic disease with AI-powered programs, cognitive behavioral lessons, data monitoring, compassionate coaching, and care coordination.
Twin Health
Twin Health
Endocrinology & Metabolic AI
Twin Health uses AI Digital Twin technology to provide precision care for metabolic conditions, offering real-time monitoring, AI-driven insights, and personalized plans to support diabetes remission and medication reduction.
Tidepool Loop
Tidepool
Endocrinology & Metabolic AI

See all Endocrinology & Metabolic AI tools →

More from AmCad BioMed

AmCAD-UO
AmCad BioMed Corporation
Radiology & Imaging AI
AmCAD-UV
AmCad BioMed
Cardiology AI
AmCAD-UV is an AI-powered ultrasound software device for vascular pulsatility analysis, quantifying and classifying ultrasonic color intensity data to assist in interpreting hemodynamic variations in blood vessels.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-10-14 | First Added: 2026-04-17
AI Tool Finder
AI-powered search. Results may not be comprehensive.